Executive Kevin Czerney of Dentsply Sirona (XRAY) acquires 1,478 shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. executive Kevin Czerney, the Vice President and Chief Accounting Officer, reported acquiring 1,478 shares of common stock as a grant or award at a price of $0.00 per share. After this award, his directly owned holdings increased to 29,630.908 shares of the company’s common stock.

The award relates to performance-based restricted stock units granted on March 3, 2023, which were certified as attained on March 2, 2026 after the company met specified performance criteria. According to the award terms, these PRSUs vest and convert into shares of common stock on March 3, 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Czerney Kevin

Role VP, Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,478	$0.00	--

Holdings After Transaction: Common Stock — 29,630.908 shares (Direct)

Footnotes (1)

[object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/03/2026 - 04:53 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Czerney Kevin

(Last)

(First)

(Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE

28277

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/02/2026		A		1,478⁽¹⁾	A	$0	29,630.908	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On March 3, 2023, the Reporting Person was granted performance-based restricted stock units ("PRSUs"). Each PRSU represents a contingent right to receive a share of the Issuer's Common Stock upon settlement. The Compensation Committee of the Issuer's Board of Directors certifies attainment based on the Issuer's satisfaction of certain performance criteria. The performance criteria were met and 1,478 PRSUs were certified as attained on March 2, 2026. The PRSUs vest and become shares of the Issuer's Common Stock on March 3, 2026.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for Kevin Czerney	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did DENTSPLY SIRONA (XRAY) executive Kevin Czerney report in this Form 4 filing?

Kevin Czerney reported acquiring 1,478 shares of DENTSPLY SIRONA common stock as a grant or award at $0.00 per share. This transaction reflects the settlement of a performance-based equity award tied to earlier performance criteria set by the company.

How many DENTSPLY SIRONA (XRAY) shares does Kevin Czerney own after this transaction?

After this transaction, Kevin Czerney directly owns 29,630.908 shares of DENTSPLY SIRONA common stock. This total includes the 1,478 shares acquired through the performance-based award, which was certified as attained based on company performance criteria on March 2, 2026.

What is the origin of the 1,478 DENTSPLY SIRONA (XRAY) shares reported by Kevin Czerney?

The 1,478 shares come from performance-based restricted stock units granted on March 3, 2023. Each PRSU represented a contingent right to receive one share of common stock, subject to satisfying performance criteria certified by the Compensation Committee on March 2, 2026.

When do Kevin Czerney’s performance-based restricted stock units in DENTSPLY SIRONA (XRAY) vest?

The performance-based restricted stock units vest and become shares of DENTSPLY SIRONA common stock on March 3, 2026. The Compensation Committee certified that the performance criteria were achieved on March 2, 2026, triggering the attainment of 1,478 PRSUs under the award terms.

What type of transaction is reported for DENTSPLY SIRONA (XRAY) insider Kevin Czerney?

The transaction is classified as an acquisition of common stock through a grant or award. It is a non-derivative transaction coded as “A,” indicating a grant, award, or other acquisition, with no cash price paid for the shares, reflecting equity-based compensation.